Corcept Therapeutics CORT 深 滬
已收盤 12-24 16:00:00 美东时间
83.59
+1.600
+1.95%
華盛通- 最 高84.48
- 今 開82.01
- 成交量 31.39万股
- 最 低 81.97
- 昨 收 81.99
- 總市值 87.77亿
- 52周最高 117.33
- 市盈率 靜 67.89
- 換手率 0.30%
- 52周最低 49.00
- 委 比 -90.63%
- 總股本 1.05亿
- 歷史最高 117.33
- 量 比 0.23
- 振 幅 3.06%
- 歷史最低 1.27
- 每 手 1
- 風險率 9.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Corcept Therapeutics' Upcoming FDA Decision: Is A CRL Likely?
Are There Red Flags in the Trial Results? Introduction: Corcept Therapeutics' (...
12-23 00:41
Top picks for 2026 from top-performing funds - Barron's
In a year where beating the market has proven challenging, a select group of stock fund managers have found winning strategies. They shared where they see opportunities ahead with Barron's. With the S...
12-22 02:46
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
12-17 10:46
UBS Initiates Coverage On Corcept Therapeutics with Neutral Rating, Announces Price Target of $95
UBS analyst Ashwani Verma initiates coverage on Corcept Therapeutics (NASDAQ:CORT) with a Neutral rating and announces Price Target of $95.
12-16 21:39
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
11-26 10:07
HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $145 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $145 price target.
11-25 20:04
Wolfe Research Initiates Coverage On Corcept Therapeutics with Peer Perform Rating
Wolfe Research analyst Kalpit Patel initiates coverage on Corcept Therapeutics (NASDAQ:CORT) with a Peer Perform rating.
11-19 01:22
Corcept Therapeutics shares are trading lower after the company reported worse-than-expected Q3 sales results and cut its FY25 sales guidance below estimates.
Corcept Therapeutics shares are trading lower after the company reported worse-...
11-05 05:43
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Uncovering Potential: Axsome Therapeutics's Earnings Preview
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings ...
11-01 02:01
